Comparison of oral morphine depots medicated once a day and twice a day as an induction of pain relief.

Comparison of oral morphine depots medicated once a day and twice a day as an induction of pain relief. - Comparison of oral morphine depots medicated once a day and twice a day as an induction of pain relief.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004362

Enrollment

Registered

2010-10-08

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Control group:oral morpine depot medicated twice a day(during one week after medication) Intervention group:oral morpine depot medicated once a day(during one week after medication)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Poorly pain-controlled patients using NSAIDs Patients with written informed consent before treatment

Exclusion criteria

Exclusion criteria: Patients without written informed consent. Patients with severe respiratory failure, bronchial asthma attack, severe hepatic disorder, chronic lung disease followed by heart failure, convulsion, acute alcoholism, a past history of hypersensitivity to morphines or opium alkaloids, and hemorrhagic colitis.

Design outcomes

Primary

Measure	Time frame
Efficacy of pain relief(during one week after medication) Frequency of resque drug medication	—

Secondary

Measure	Time frame
Evaluation of side effects	—

Countries

Japan

Contacts

Public ContactKazunori Fujitaka

Hiroshima University Hospital respiratory medicine

fujikazu@hiroshima-u.ac.jp082-257-5198

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026